Skip to content
Clinical Trials – home
Verifiedinfo

Praxis Ebertplatz

Germany Ebertplatz 1, 50668 Cologne, Germany

  • 1 trial recruiting
  • HIV infection · COVID-19 · Chronic hepatitis B
  • Adults and children

About Specializations

Praxis Ebertplatz in Cologne, Germany specialises in clinical trials of conditions such as HIV infection, COVID-19, Chronic hepatitis B, Hepatitis B, and other specialisations. This site conducts important research.

Main research areas of the site

HIV-1 Treatment Innovations

The medical center is at the forefront of HIV-1 treatment research, focusing on innovative therapeutic strategies to enhance patient outcomes. The center's research is dedicated to evaluating the efficacy of novel treatment regimens, such as the combination of bictegravir and lenacapavir, in maintaining viral suppression in individuals who are already successfully treated.

  • Novel Antiretroviral Therapies
  • Virological Suppression Strategies
  • Patient-Centric Treatment Approaches

Through its pioneering research, the center contributes significantly to the development of more effective and patient-friendly treatment options, aiming to improve the quality of life for those living with HIV-1.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ebertplatz 150668 CologneGermany
Recruiting now
1 trial
Conditions studied
4
Partner status
Verified

More sites in CologneGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:IBUZATRELVIR
  • Sponsor:Pfizer Inc.

HIV infection

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cabotegravir
  • Sponsor:Viiv Healthcare UK Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Gilead Sciences Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bepirovirsen
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Viiv Healthcare UK Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pamapimod
  • Sponsor:Kinarus AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).